Advertisement.

EVOK Projected Dividend Yield

Com Par $0.0001/Evoke Pharma Inc ( NASDAQ : EVOK )

Evoke Pharma is a pharmaceutical company focused primarily on the development and commercialization of drugs to treat gastrointestinal disorders and diseases. Co. is focused on developing its primary product, Gimoti (metoclopramide) nasal spray. Gimoti is a dopamine antagonist / mixed 5-HT3 antagonist / 5-HT4 agonist for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. Gimoti is a formulation of metoclopramide providing delivery by nasal spray administration. Co. is party to a commercial services agreement with Eversana Life Science Services, LLC, or Eversana, pursuant to which Eversana commercializes and distributes Gimoti in the U.S.

20 YEAR PERFORMANCE RESULTS

EVOK Dividend History Detail
EVOK Dividend News
EVOK Competitors News

# of Shares: 0

Closing Price: 4.71

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000